We analyzed postdiagnosis fasting C-peptide in relation to all causes of death and breast cancer deaths among 546 women without type 2 diabetes and ... Eighty percent of the non–breast cancer deaths ...

The shaded area shows the glucose range of 70 to 180 mg per deciliter (3.9 to 10.0 mmol per ... and the BETA-2 score (calculated from the fasting C-peptide level, the fasting glucose level, ...

At this time point, fasting C-peptide levels increased to 404 pmol/L and HbA1c dropped down to 6.7%. Time spent in target range also increased to 81.4%. ... and spent 99.9% of time in target range.

Fasting C-peptide was used in these models in place of the insulin measurement among nisei for empiric reasons, because C-peptide proved to be a stronger predictor of diabetes occurrence in ...

Background: A recently halted clinical trial showed that intensive treatment of type 2 diabetes mellitus was associated with increased mortality. Given the phenotypic heterogeneity of diabetes, ...

The fasting C-peptide level increased in all the patients to a mean of 1.05±0.40 ng per milliliter, and the time-in-range was 89±3% according to continuous glucose monitoring.

After the VX-880 infusion, this second patient experienced an increase in time in range from 35.9% at baseline to 51.9% at the day 121 to 150 interval, as well as a reduction in insulin of 18.2 U ...